These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 5921888)

  • 1. Toxicity of beta-diethylaminoethyl diphenylpropylacetate (SKF-525A) in cats.
    Gaitondé BB; Borison HL
    Toxicol Appl Pharmacol; 1966 Jan; 8(1):118-25. PubMed ID: 5921888
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of beta-diethylaminoethyl-diphenylpropylacetate (SKF-525-A) on biological membranes. I. Induced stimulation of human erythrocytes.
    Lee IP; Dixon RL
    Proc West Pharmacol Soc; 1968; 11():47-8. PubMed ID: 5734483
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of cytochrome P-450 with 2-diethylamino-ethyl-2,2-diphenylpropylacetate (SKF-525A) reduces immunotoxicity of chlorinated carbohydrates.
    Zabrodskii PF; Mandych VG; Germanchuk VG
    Bull Exp Biol Med; 2006 Sep; 142(3):324-6. PubMed ID: 17426840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opiate properties of SKF 525A.
    Ho TK; LaBella FS; Pinsky C
    Can J Physiol Pharmacol; 1978 Aug; 56(4):550-4. PubMed ID: 210915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of SKF-525A and of altered hepatic blood flow on lidocaine clearance in the cat.
    Lautt WW; Skelton FS
    Can J Physiol Pharmacol; 1977 Feb; 55(1):7-12. PubMed ID: 843992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective blockade of potassium-induced contractions of aortic strips by beta-diethylaminoethyl-diphenylpropylacetate (SKF 525A).
    Kalsner S; Nickerson M; Boyd GN
    J Pharmacol Exp Ther; 1970 Sep; 174(3):500-8. PubMed ID: 4318489
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of -diethylaminoethyl-diphenylpropylacetate (SKF 525-A) on biological membranes. II. SKF 525-A-induced effects on the growth and uptake of L-amino acids by Escherichia coli (diploid mutant).
    Lee IP
    Biochem Pharmacol; 1973 May; 22(9):1075-82. PubMed ID: 4572031
    [No Abstract]   [Full Text] [Related]  

  • 8. SKF 525A displaces drugs from serum alpha 1-acid glycoprotein binding sites.
    Belpaire FM; Chindavijak B; Bogaert MG
    J Pharmacol Exp Ther; 1987 Feb; 240(2):628-30. PubMed ID: 3806415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alteration in the magnitude of induction of tyrosine transaminase by glycocorticoids. The effects of phenobarbital, o,p'DDD and beta-diethylaminoethyl diphenylpropylacetate (SKF 525A).
    Kupfer D
    Arch Biochem Biophys; 1968 Sep; 127(1):200-6. PubMed ID: 4386644
    [No Abstract]   [Full Text] [Related]  

  • 10. Potentiation by SKF 525A of the pressor responses to catecholamines, oxytocin and carotid occlusion in rats.
    Krstić MK
    Arch Int Pharmacodyn Ther; 1984 May; 269(1):52-62. PubMed ID: 6466007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolite involvement in the behavioral effects of bromocriptine in cats.
    Gonzalez-Lima F; Hart WT; Rivera-Quinones C
    Eur J Pharmacol; 1987 Sep; 141(1):109-15. PubMed ID: 3666021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. beta-Diethylaminoethyl-diphenylpropylacetate (SKF 525-A) enhancement of tissue accumulation of aldrin in mice.
    Clark CR; Krieger RI
    Toxicol Appl Pharmacol; 1976 Nov; 38(2):315-23. PubMed ID: 996862
    [No Abstract]   [Full Text] [Related]  

  • 13. The cytochrome P450 inhibitor SKF-525A disrupts autophagy in primary rat hepatocytes.
    Luo Y; Yang X; Shi Q
    Chem Biol Interact; 2016 Aug; 255():55-62. PubMed ID: 26964495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of 2,4-dichloro-6-phenoxyethyl-amine (DPEA) and -diethylaminoethyl diphenylpropylacetate (SKF-525A) on hepatic microsomal azoreductase activity from phenobarbital or 3-methylcholanthrene induced rats.
    Shargel L; Mazel P
    Biochem Pharmacol; 1972 Jan; 21(1):69-75. PubMed ID: 4400525
    [No Abstract]   [Full Text] [Related]  

  • 15. Alteration in the magnitude of induction of tyrosine transaminase by glucocorticoids. II. Effects of phenobarbital, o,p' DDD and diethylaminoethyl diphenylpropylacetate (SKF 525A) on metabolism of triamcinolone acetonide.
    Kupfer D; Partridge R; Jones TM
    Arch Biochem Biophys; 1969 Apr; 131(1):57-66. PubMed ID: 4388684
    [No Abstract]   [Full Text] [Related]  

  • 16. Blockade by SKF 525A of the rat sympathetic ganglia and the adrenal medulla.
    Krstić MK
    Arch Int Pharmacodyn Ther; 1976 Sep; 223(1):64-70. PubMed ID: 999403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of beta-diethylaminoethyl-diphenylpropylacetate HCl (SKF 525-A) on canine heart mitochondrial function.
    Mukherjee A; Krishnamurty VS
    Biochem Pharmacol; 1980 Feb; 29(3):283-8. PubMed ID: 6444816
    [No Abstract]   [Full Text] [Related]  

  • 18. Interaction of secalonic acid D with phenobarbital, 3-methyl cholanthrene, and SKF-525A in mice.
    Reddy CS; Reddy RV; Hayes AW
    J Toxicol Environ Health; 1983; 12(4-6):687-94. PubMed ID: 6668617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of beta-diethylaminoethyl-diphenylpropylacetate (SKE 525-A) on biological membranes. I. SKF 525-A-induced stabilization of human erythrocytes.
    Lee IP; Yamamura HI; Dixon RL
    Biochem Pharmacol; 1968 Aug; 17(8):1671-81. PubMed ID: 5672827
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacological methods of estimating inhibition of drug oxidation in the mouse.
    LESSIN AW
    Br J Pharmacol Chemother; 1959 Jun; 14(2):251-5. PubMed ID: 13662584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.